FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


23627 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Cannabinoid - non-pharmaceutical Cannabis (substance)
Cannabis dependence with current use Cannabis dependence
Cannabis grass - non-pharmaceutical Cannabis (substance)
Cannabis leaves - non-pharmaceutical Cannabis leaf (substance)
Cannabis oil - non-pharmaceutical Cannabis oil (substance)
Cannabis resin - non-pharmaceutical Cannabis resin (substance)
Cannulation - action Insertion - action (qualifier value)
Cannulation of vessel NOS Vascular cannula insertion
Cannulation of vessel NOS Vascular cannula insertion
Capillary hemangioma - category Capillary hemangioma
Capnocytophaga canimorsus Capnocytophaga canimorsus
Caprine adenovirus Goat adenovirus (organism)
Capsaicin 179mg/hour transdermal patch Product containing precisely capsaicin 179 milligram/1 each conventional release cutaneous patch (clinical drug)
Capsule of distal interphalangeal joint of great toe Structure of capsule of interphalangeal joint of great toe
Captopril allergy Non-allergic hypersensitivity to captopril (finding)
Carbachol 1% eye drops Product containing precisely carbachol 10 milligram/1 milliliter conventional release eye solution (clinical drug)
Carbachol 1.5% eye drops Carbachol 15 mg/mL eye solution
Carbachol 1.5% solution Carbachol 15 mg/mL eye solution
Carbachol 250micrograms/mL intraocular injection solution 1mL ampule Product containing precisely carbachol 250 microgram/1 milliliter conventional release solution for injection (clinical drug)
Carbamazepine 100mg m/r capsule Carbamazepine only product in oral dose form
Carbamazepine 100mg m/r tablet Carbamazepine only product in oral dose form
Carbamazepine 100mg prolonged-release oral capsule Carbamazepine only product in oral dose form
Carbamazepine 100mg prolonged-release oral tablet Carbamazepine only product in oral dose form
Carbamazepine 200mg m/r capsule Carbamazepine only product in oral dose form
Carbamazepine 200mg prolonged-release oral capsule Carbamazepine only product in oral dose form
Carbamazepine 300mg m/r capsule Carbamazepine only product in oral dose form
Carbamazepine 300mg prolonged-release oral capsule Carbamazepine only product in oral dose form
Carbapenem-resistant Klebsiella pneumonia Carbapenem resistant Klebsiella pneumoniae (organism)
Carbenoxolone sodium 1% mouthwash granules Carbenoxolone only product
Carbenoxolone sodium 2% oral gel Carbenoxolone 20 mg/g oromucosal gel
Carbidopa + levodopa 25mg/100mg m/r tablet Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet
Carbidopa + levodopa 50mg/200mg m/r tablet Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
Carbidopa 10mg/levodopa 100mg orally disintegrating tablet Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)
Carbidopa 18.75mg + levodopa 75mg + entacapone 200mg tablet Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet
Carbidopa 25mg Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram/1 each conventional release oral tablet (clinical drug)
Carbidopa 25mg/levodopa 100mg orally disintegrating tablet Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)
Carbidopa 25mg/levodopa 250mg orally disintegrating tablet Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 1mg/1mL/4mg/1mL/15mg/1mL drop Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/12.5mg/5mL/60mg/5mL syrup Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/15mg/5mL/60mg/5mL syrup Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+pseudoephedrine hydrochloride 1mg/1mL/15mg/1mL drops Carbinoxamine maleate 1 mg/mL and pseudoephedrine hydrochloride 15 mg/mL oral solution
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg m/r tablet Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form)
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg prolonged-release oral tablet Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form)
Carbohydrate agent Carbohydrate
Carbol fuchsin stain Carbol-fuchsin (substance)
Carbon-carbon lyase Carbon-carbon lyase
Carbon-halide lyase Carbon-halide lyase
Carbon-nitrogen lyase Carbon-nitrogen lyase
Carbon-oxygen lyase Carbon-oxygen lyase
Carbon-sulfur lyase Carbon-sulfur lyase (substance)
Carboplatin 600mg/60mL infusion Antineoplastic agent (substance)
Carboxy-lyase Decarboxylase
Carboxylic ester hydrolase Carboxylesterase
Carboxymethylcellulose sodium + hydroxyapatite injectable implant 1mL syringe Carmellose and hydroxyapatite only product in parenteral dose form
Carboxymethylcellulose sodium 16.58% oral paste Carmellose 166 mg/g oromucosal paste
Carbuncle of head, except face Carbuncle of head
Carbuncle of other specified site Carbuncle of skin and/or subcutaneous tissue (disorder)
Carcinoid bronchial adenoma Carcinoid tumour of bronchus
Carcinoid bronchial adenoma Well-differentiated neuroendocrine tumor (morphologic abnormality)
Carcinoid tumor Well-differentiated neuroendocrine tumour
Carcinoid tumor - morphology Well-differentiated neuroendocrine tumor (morphologic abnormality)
Carcinoid tumor no International Classification of Diseases for Oncology subtype Well-differentiated neuroendocrine tumor (morphologic abnormality)
Carcinoid tumor of ampulla of Vater Well-differentiated neuroendocrine tumor of ampulla of Vater (disorder)
Carcinoid tumor of appendix Well-differentiated neuroendocrine tumor of appendix (disorder)
Carcinoid tumor of gastrointestinal tract Well-differentiated neuroendocrine tumor of gastrointestinal tract
Carcinoid tumor of ileum Well-differentiated neuroendocrine tumor of ileum
Carcinoid tumor of intestine Well-differentiated neuroendocrine tumour of intestine
Carcinoid tumor of large intestine Well-differentiated neuroendocrine tumor of large intestine
Carcinoid tumor of pancreas Neuroendocrine tumor of pancreas (disorder)
Carcinoid tumor of rectum Well-differentiated neuroendocrine tumour of rectum
Carcinoid tumor of small intestine Well-differentiated neuroendocrine tumor of small intestine (disorder)
Carcinoid tumor of stomach Well-differentiated neuroendocrine tumour of stomach
Carcinoid tumor of uncertain malignant potential Well-differentiated neuroendocrine tumor (morphologic abnormality)
Carcinoma in situ - category Carcinoma in situ (morphologic abnormality)
Carcinoma in situ NOS Carcinoma in situ (disorder)
Carcinoma in situ NOS Carcinoma in situ (disorder)
Carcinoma in situ neoplastic process Carcinoma in situ (morphologic abnormality)
Carcinoma in situ of areola of female breast Carcinoma in situ of areola (disorder)
Carcinoma in situ of areola of male breast Carcinoma in situ of areola (disorder)
Carcinoma in situ of axillary tail of female breast Carcinoma in situ of axillary tail of breast
Carcinoma in situ of central portion of female breast Carcinoma in situ of central portion of breast (disorder)
Carcinoma in situ of ectopic female breast tissue Carcinoma in situ of ectopic site of breast (disorder)
Carcinoma in situ of ectopic male breast tissue Carcinoma in situ of ectopic site of breast (disorder)
Carcinoma in situ of female breast Carcinoma in situ of breast
Carcinoma in situ of lower inner quadrant of female breast Carcinoma in situ of lower inner quadrant of breast
Carcinoma in situ of lower outer quadrant of female breast Carcinoma in situ of lower outer quadrant of breast (disorder)
Carcinoma in situ of male breast Carcinoma in situ of breast
Carcinoma in situ of nipple of female breast Carcinoma in situ of nipple (disorder)
Carcinoma in situ of nipple of male breast Carcinoma in situ of nipple (disorder)
Carcinoma in situ of other and unspecified female genital organs Carcinoma in situ of female genital organ
Carcinoma in situ of other and unspecified female genital organs Carcinoma in situ of female genital organ
Carcinoma in situ of other and unspecified male genital organs Carcinoma in situ of male genital organ
Carcinoma in situ of other and unspecified male genital organs Carcinoma in situ of male genital organ
Carcinoma in situ of skin of other and unspecified parts of face Carcinoma in situ of skin of face
Carcinoma in situ of skin of other and unspecified parts of face Carcinoma in situ of skin of face
Carcinoma in situ of skin of other and unspecified parts of face NOS Carcinoma in situ of skin of face
Carcinoma in situ of upper inner quadrant of female breast Carcinoma in situ of upper inner quadrant of breast
Carcinoma in situ of upper outer quadrant of female breast Carcinoma in situ of upper outer quadrant of breast
Carcinoma in situ tumour Carcinoma in situ (disorder)
Carcinoma in situ, no International Classification of Diseases for Oncology subtype Carcinoma in situ (morphologic abnormality)

Start Previous Page 30 of 237 Next End


Reference Sets

Reference set descriptor

Back to Start